Medtronic plc (NYSE: MDT) is among the 15 Best Boring Dividend Stocks to Buy. Barclays raised its price target on MDT to $111 from $109, maintaining an Overweight rating after a strong quarter. For the second quarter of fiscal 2026, MDT reported sales of $9 billion, a 6.6% increase compared to the previous year, with adjusted earnings per share rising 8% year over year to $1.36. The cardiovascular segment was a key contributor to MDT’s strong results, with revenue reaching $3.4 billion, up 10.8% year over year. Medtronic plc continues to innovate and launch new products while maintaining a vast portfolio of devices. They aim to treat a wide variety of health conditions to reduce pain, restore health, and extend life.

Read more at Yahoo Finance: Barclays Adjusts Medtronic (MDT) Forecast After Encouraging Earnings Report